Sign In

Gaurav Nukala

Head of Product & Technology | 3X Unicorns, Apple | 0 -> 1, Growth, Partnerships

Gaurav Nukala is a seasoned professional in the fields of technology and medicine, currently serving as the Interim Chief Product and Technology Officer (CPTO) and an AI Consultant. His experience spans multiple organizations, including Johnson & Johnson Innovative Medicine, Snappt, and RhythmX.ai, among others, where he has contributed significantly to product management and AI initiatives.

Educational Background

Nukala has a strong academic foundation, having attended prestigious institutions such as:

  • Massachusetts Institute of Technology (MIT)
  • Duke University (including The Fuqua School of Business)

Professional Experience

In his current role at Johnson & Johnson, he focuses on integrating advanced technologies into healthcare solutions. His work at Snappt and RhythmX.ai further emphasizes his expertise in leveraging AI for innovative product development.

Online Presence

Nukala is active on LinkedIn, where he shares insights about his professional journey and engages with a network of over 4,000 followers. His posts often reflect on his experiences in various companies and the evolving landscape of AI in product management.

Overall, Gaurav Nukala is recognized for his contributions to technology in medicine and his leadership in AI-driven projects.

Highlights

Aug 20 · linkedin

In some of the companies I was part of, we struggled with the percentage allocation of engineering resources between new capabilities and other technically oriented activities. ICONIQ Capital has published benchmarks that seem quite reasonable for a company in the growth phase; however, I don't think these benchmarks apply to much earlier stage companies.

While other categories are self-explanatory, KTLO (Keep The Lights On) essentially refers to the minimum time allocation needed to maintain security posture, ensure current levels of uptime, and stay up to date with libraries, hardware, and partner changes.

https://lnkd.in/g7rJBGUj

Aug 15 · linkedin

There are various considerations before moving a AI product demo into production.

► Reliability, Harmlessness, Factual consistency, Relevancy, Scalability, Cost, Security, Privacy, GDPR, CCPA, Fairness, and on and on...

🔴 If founders try to tackle all requirements at once during the early stages of AI product development, they will struggle to ship fast, learn, and iterate.

🔵 For the use case you are building, identify the considerations that are non-negotiable. Calibrate your risk tolerance based on the use case you are building. A big no no for a Healthcare app to not rank safety as a top priority.

🔵 Ruthlessly prioritize the considerations with a goal of shipping faster and iterating. Your GTM strategy will inform ( at least partly) the criteria for prioritization. Be strategic about your launch vertical, launch geography, and business model.

Related Questions

What are Gaurav Nukala's main responsibilities at Johnson & Johnson Innovative Medicine?
How did Gaurav Nukala transition from being employed to self-employed?
What projects has Gaurav Nukala worked on at Snappt and RhythmX.ai?
What is Gaurav Nukala's educational background?
How does Gaurav Nukala's role as CPTO differ from traditional CTO roles?
Gaurav Nukala
Gaurav Nukala, photo 1
Gaurav Nukala, photo 2
Add to my network

Location

San Francisco Bay Area